Insmed Incorporated
INSM
Clasificación en acciones
#1108
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Precio por acción
$95.88
Capitalización bursátil
$20.94B
Cambio (1 día)
0.61%
Cambio (1 año)
-42.90%
País
US
Comercio Insmed Incorporated (INSM)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Insmed Incorporated (INSM)
La acción Insmed Incorporated (símbolo: INSM) tuvo un total de 2 desdoblamientos.
El desdoblamiento más reciente ocurrió el Mar 03, 2011.
Una acción INSM comprada antes de Jul 31, 2000 equivaldría hoy a 0.025 acciones INSM.
El desdoblamiento más reciente ocurrió el Mar 03, 2011.
Una acción INSM comprada antes de Jul 31, 2000 equivaldría hoy a 0.025 acciones INSM.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2011-03-03 | 1:10 | x0.1 | x0.025 |
| 2000-07-31 | 1:4 | x0.25 | x0.25 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
